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The ethnobotanical, anthropological and ethnopharmacological literature has shown a strong relationship between hallucinogenic plants and 
medical efficacy. Despite evidence from previous studies, many issues have not been discussed clearly enough to enable acceptance of this relationship. This 
study uses a literature survey to track how different authors have dealt with the issue and what future research opportunities may emerge.  
 
 












La literatura etnobotánica, antropológica y etnofarmacológica ha señalado una fuerte relación entre las plantas alucinógenas y su efectividad como 
medicamento. A pesar de todas las pruebas e informes, hay muchas cuestiones que no están claramente discutidas para permitir la aceptación de esta idea. En 
este trabajo, a partir de una investigación bibliográfica, nos proponemos investigar cómo diferentes autores se han ocupado de la cuestión y cuáles son las 
posibilidades de investigación que puedan emerger de esto. 
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 Hallucinogens have been used by human 
communities since ancient times. For example, 
records of the use of the plant Sophora secundiflora 
(Gomez-Ortega) Lag. ex DC. dating from between 
8440 and 8129 BC have been found in the state of 
Texas, in the southern United States (Furst, 2004). 
According to some authors, psychoactive drugs are 
capable of causing not only visual hallucinations but 
also auditory, tactile and gustatory ones. Because of 
these characteristics, they are often believed to 
mediate communication with gods or spirits (Schultes 
& Hofmann, 1993; Rodrigues, 2001; De Feo, 2004), 
earning them the name “entheogens.” This term was 
coined by Gordon Wasson (Wasson et al., 1992) and 
means “god within me,” a reference to the fact that 
when such substances are ingested they establish a 
closer connection between the person who consumes 
them and the gods.  
Aside from their use as hallucinogens, plants 
or fungi with these properties have varied uses. For 
example, the plant nutmeg (Myristica fragrans 
Houtt.) is used as a seasoning (Weil, 1965), and 
marijuana (Cannabis sativa L.) is used as a source of 
textile fiber (Schultes & Hofmann, 1993). However, 
perhaps no other use has been so often reported as the 
medicinal use of these plants (Bruhn & Bruhn, 1973; 
Dunn, 1973, Souza et al., 2008; Rodrigues et al., 
2008).  
In an article entitled "Mescaline Cactus Used 
in Folk Healing", Dobkin de Rios (1968) reports the 
hallucinogenic and medicinal use of San Pedro cactus 
(Trichocereus pachanoi Britton & Rose) in a rural 
community in Peru, suggesting that psychoactive 
substances are effective in treating diseases. 
However, the author showed that although the use of 
hallucinogenic plants in curing disease was 
mentioned by several authors, the use of such plants 
in medicinal contexts had not been adequately 
discussed.  
Although several authors have already 
suggested this hypothesis, it is a topic deserving of 
further attention. Therefore, we performed a literature 
review on research that addresses the use of 
hallucinogens. We conducted searches of the 
databases JSTOR, Scopus, Science Direct and Web of 
Science and magazines like the Journal of 
Ethnopharmacology and Economic Botany using the  
keywords: psychoactive plants, hallucinogenic plants, 
psychedelic plants, central nervous system, 
entheogen, entheogenic, and narcotic, in combination 
with the keywords medical, medicine, heal, healing 
and therapeutic.  
In this paper, we present some considerations 
for developing the hypothesis, which often do not 
appear clearly in the literature. We then present 
previous findings on the treatment of diseases using 
hallucinogens, including the different actions of 
psychoactive drugs and other elements that can 
interact in the treatment of diseases. 
HALLUCINOGENS AND THEIR 
EFFECTIVENESS IN CURING DISEASES: 
INITIAL THOUGHTS 
Considerations about hallucinogenic and 
medicinal uses  
 The use of hallucinogenic substances as 
medicine has been recognized in traditional 
communities, but little academic study has been done 
on this relationship. Many studies combine medicinal 
and hallucinogenic properties of plants into the same 
category, recognizing hallucinogens as a secondary 
feature of some species used in traditional medicine 
(see Schultes, 1938; Rodríguez & Cavin, 1982). For 
example, Weiner (1971), working in a rural 
community in Tonga (a country located east of 
Australia), wondered about a strange absence of 
hallucinogenic plants in traditional medicine, which 
shows a close relationship between the hallucinogenic 
and medicinal uses for this author. 
We believe that this strong relationship 
between hallucinogenic and medicinal uses may be 
due to something Paracelsus had already noted in the 
sixteenth century, the fact that different 
concentrations of a substance alter its effect on those 
who ingest it. Thus, the same substance could be used 
for medical, narcotic or poisonous purposes 
depending on the dosage (Schultes & Hofmann, 
1993). Similar examples can be found in Souza et al. 
(2008) on the use of the plant Jurema (Mimosa 
tenuiflora) by the indigenous people in Brazil and 
Rodrigues et al. (2008) in the study of the 
hallucinogenic cigarette “Tira-capeta” used by the 
Quilombolas (Afro-Brazilian slaves descendants) 
communities in Brazil.  
Ferreira-Junior  et al. Hallucinogenic plants in curing disease 
 
        Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas Vol.9 (4) 2010 | 294 
 
 
Many authors have shared this idea (Weil, 
1965; Rodríguez & Cavin, 1982; Etkin, 1988; 
Brussell, 2004), proposing that the hallucinogenic 
effects of plants were discovered subsequent to their 
medical applications when users of these drugs took 
higher doses than recommended. This seems to have 
been the case with nutmeg, according to a report by 
Weil (1965). Rodríguez & Cavin (1982) suggested 
that many hallucinogenic plants were initially used 
for treatment of diseases due to their emetic 
properties, with the understanding that these 
properties would induce a purification of the body. 
Subsequently, according to the authors, the 
hallucinogenic properties indicated the appropriate 
doses for the medicine to have an effect.  
  Given the evidence, there seems to be a belief 
among researchers that these substances may alter the 
mind, not just in terms of their hallucinogenic effects, 
but also in a medicinal context (Randolph, 1905). 
However, we must separate the two perspectives that 
seem to emerge from the works of these authors. The 
cure can be interpreted from the perspective of the 
researcher (the biomedical model) or from the 
perspective of the culture studied. For example, if an 
investigator witnesses a shamanic ritual including the 
ingestion of a psychoactive substance and records 
testimony that it healed the patient, we must 
distinguish whether the cure was actually achieved at 
a physiological level or in the sphere of "cultural 
diseases," those related to the worldview and beliefs 
of a particular people. Often these distinctions do not 
appear in the texts. Thus, there are different concepts 
of illness and healing.   
 
Difference in the concept of disease in traditional 
and modern communities  
Determining the moment when it began to 
consider medicinal plants to also be hallucinogens is 
no easy task, because the concept of disease for 
traditional cultures often differs from what “disease” 
means to Westernized or modern people (Hurrell, 
1991; Herndon et al., 2009). However, if our goal is 
to investigate whether hallucinogens are effective in 
the treatment of diseases, we must first define what a 
disease is (La Barre, 1979). We will adopt an 
approach based on the biomedical model to evaluate 
the effectiveness for both medicinal and 
hallucinogenic applications.  
This subject has been extensively studied 
(Coelho, 1976; Monod, 1976; Rodríguez & Cavin, 
1982; Fackelmann, 1993; Menéndez, 1994; Agosta, 
1997; Rodrigues, 2001; Shepard Jr., 2002; De Feo, 
2004; Toledo, 2006; Bourbonnais-Spear et al., 2007). 
Most of these authors indicate that, in addition to 
recognizing what we might call physiological 
diseases (diseases that would be accepted by modern 
medical science), many traditional communities also 
recognize diseases caused by supernatural agents 
(see, for example, Garro, 2000).  
Schultes & Hofmann (1993) argue that non-
industrialized cultures do not differentiate between 
physiological and supernatural causes for disease. 
Rather, disease is the result of "interference with the 
spiritual world." Therefore, the best medicine to treat 
diseases would be entheogens, which enable contact 
with the spiritual world where an effective cure for 
the disease can be identified. This complex process is 
difficult to explain without systematic and specific 
case studies. A hallucinogenic plant may have 
medicinal properties that treat some (but not all) 
physical infirmities. If a particular healing ritual 
always uses the same plants to treat a complex of 
several diseases, it would be reasonable to assume 
that the cure operates not at a physical level, but at a 
supernatural level, according to the worldview of the 
culture. Considering the cause of a disease to be other 
than physiological, or even to be supernatural, usually 
means the cure is also not "conventional," and that it 
does not fit the types of treatments recognized by 
modern medical science.  
ARE HALLUCINOGENS EFFECTIVE IN 
TREATING DISEASE?   
From the bibliographical material examined, 
we classified the treatment of diseases using 
psychoactive drugs into three groups, according to the 
role of hallucinogens the treatment.   
Indirect action of hallucinogens in the treatment of 
diseases 
Agosta (1997), in a review of plant 
compounds used as medicinal, noted that in 
traditional communities, diseases are often thought to 
be caused by evil spirits. Therefore, healers should 
administer psychotropic drugs and use their influence 
to communicate with the spirit world and achieve the 
patient's healing. According to Schultes (1979), 
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healers and shamans take hallucinogens to make 
contact with deities through visions or dreams. These 
visions provide knowledge about the disease 
afflicting the patient and tell the healers the proper 
treatment of the condition (see also Rodrigues, 2001; 
De Feo, 2004). In this case, the entheogen becomes a 
vehicle that allows the healer to explore aspects of the 
disease and treat the patient. Thus, the hallucinogen 
has an indirect effect, because it is ingested by the 
healer and not by the patient.  
In other situations, the treatment is indirect 
not because the hallucinogens allow contact with the 
gods to determine the cure for the disease, but 
because healers can use hallucinogens to confront and 
combat diseases through symbolic battles with cause 
of the disease (Rivier & Lindgren, 1972).  
 
Direct use of hallucinogens in the treatment of diseases  
In the case presented by Dobkin de Rios 
(1968), the San Pedro cactus is used to cure diseases 
through an indirect ritual treatment in which the 
healer drinks the entheogen and receives information 
about the cause of the disease. However, Dobkin de 
Rios explains in his description of the ritual that both, 
the patient and the healer, drink the infusion from the 
San Pedro cactus, an act that leads to hallucinations 
and vomiting in the patient who ingested the 
substance. Both Dobkin de Rios and Rodríguez & 
Cavin (1982) suggest that this may have a curative 
effect.   
This example shows that sometimes the 
treatment can produce indirect contact between the 
deities and the healer who ingests the drink, as well as 
a direct effect on the patient, who also ingests the 
drink. A similar report can be found in Rodrigues et 
al. (2008) on the hallucinogenic cigarette tira-capeta, 
used in healing rituals in Maroon communities in 
Brazil. According to the authors, the cigarette is used 
by both the healer and the patient, which may exert a 
direct effect on the latter in the treatment of disease. 
The key issue in these examples is that the act of 
vomiting or smoking may have more of a symbolic 
effect than a strictly physiological effect in fighting a 
specific disease.  
This is a direct treatment because the patient 
came into direct contact with the hallucinogenic 
substance, which could have an effect in curing the 
disease. Healing through direct treatment is in 
agreement with Western biomedical concepts. That 
is, the patient takes the hallucinogen, which has one 
or more bioactive compounds with medicinal 
properties. In addition, the vehicle used (e.g., powder, 
beverage or cigarette) and how the substance is 
consumed contribute to the effect of the active 
principle in the body.  
As weak evidence for direct treatment, some 
studies have isolated and identified substances with 
hallucinogenic and medicinal properties in the same 
plant, which corroborates the idea that plants with 
hallucinogenic properties also have medicinal 
properties. However, we must discern whether these 
substances can actively treat targeted diseases. For 
example, Mackie et al. (1955) proved the efficacy of 
the substance thujone, a constituent of essential oils 
from various plants, as an anthelmintic. This 
substance was also reported by Albert-Puleo (1978) 
to be a hallucinogen, demonstrating that a substance 
may in fact have both hallucinogenic and medicinal 
properties.   
Table 1 presents species of plants and fungi 
with compounds that have proven hallucinogenic 
and/or medicinal pharmacological properties. As 
shown in the table, there are substances that have 
confirmed hallucinogenic properties, but where no 
studies have demonstrated their medicinal properties, 
for example, muscimol and ibotenic acid in the 
Amanita muscaria species. Other substances, 
however, have already been proven to have both 
medicinal and hallucinogenic properties (see Table 
1). Indeed, this evidence seems to indicate that the 
initial consumption of a plant for medicinal purposes 
could lead to the discovery of its use as a 
hallucinogen. 
These examples show that hallucinogens can have 
both a direct and an indirect role in curing diseases 
while also facilitating communication with deities, 
thus allowing healers to decipher the origins of 
diseases or to symbolically battle diseases. In contrast 
to the types of treatments already mentioned, Schultes 
& Hofmann (1993) have discussed a ritual in which 
only the patient drinks a hallucinogenic substance 
while the shaman observes the behaviours and 
responses to the drink and diagnoses the patient‟s 
maladies. This example presents a third type of 
disease treatment involving hallucinogens, but does 
not suggest any medicinal properties. Thus, there may 
be a cultural placebo effect in which particular 
cultural expectations cause a member of the culture to 
attain the desired effect even without 
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Table 1.  List of species recorded in hallucinogen use and their substances with hallucinogenic and/or medicinal properties proven from 
pharmacological studies. 
 
Species Substances Properties References 
Amanita muscaria (L.: Fr.) Lam. Muscimol Hallucinogenic Perry & Perry (1995); Satora et al. 
(2005) 
 Ibotenic acid Hallucinogenic Satora et al. (2005) 
Atropa belladona L. Atropine Medicinal and 
hallucinogenic 
Rates (2001); Shultes & Hofmann 
(1993) 
 Hiosciamine; hyoscine Hallucinogenic van Dongen & Groot (1995); 
Schultes & Hofmann (1993) 
Brugmansia arborea (L.) Lagerh. Tropane alkaloids 
(atropine and 
scopolamine) 
Hallucinogenic van der Donck et al. (2004) 







de" and "oleamide") 









Medicinal Radwan et al. (2009) 
 Cannabinoids 
(Cannabicromano) 
Medicinal Ahmed et al. (2008) 
 Cannabinoids Medicinal Velasco et al. (2004); Beaulieu & 
Rice (2002) 
  Medicinal and 
hallucinogenic 
Ashton (2001); Honório et al. 
(2006); Bonfá et al. (2008); Ameri 
(1999) 
Claviceps purpurea (Fr.) Tul. Ergot alkaloids 
(ergotamine and 
ergometrine) 
Medicinal Komarova & Tolkachev (2001); 
Lorenz et al. (2009) 
 Ergot alkaloids Medicinal and Eadie (2003) 
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van Dongen & Groot (1995) 
Datura spp.  Tropane alkaloids 
(atropine and 
scopolamine) 
Hallucinogenic Perry & Perry (1995) 
Datura stramonium L. Atropine Medicinal Irambakhsh et al. (2010) 
 Atropine Medicinal and 
hallucinogenic 
Rates (2001) 
Digitalis spp. Digoxine Medicinal Rates (2001) 
Nicotiana sp. Harmine Hallucinogenic Davis et al. (1969).  
Papaver somniferum L. Codeine Medicinal Rates (2001) 
Psilocybe spp. Psilocybin Hallucinogenic Schultes (1998); Huhn et al. (2005) 
Salvia divinorum Epling & 
Játiva 
Salvinorin A Medicinal and 
hallucinogenic 
Capasso et al. (2006) 
Tabernanthe iboga Baill. Ibogaine Hallucinogenic Kubiliené et al. (2008); Sheppard 
(1994) 
 Ibogaine Medicinal and 
hallucinogenic 
Popik & Wróbel (2001) 
Trichocereus pachanoi Britton & 
Rose 
Mescaline Hallucinogenic La Barre (1979) 
Trichocereus williamsii (Lem. Ex 
Salm-Dyck) Coult. 
Mescaline Hallucinogenic La Barre (1979) 
 
 
pharmacological elements. For example, 
Albuquerque & Chiappeta (1994) describe a ritual 
with the plant Jurema in which one of the them 
consumed the drink offered, but did not have the 
same reactions that the others had (cult practitioners).  
In addition to the situations presented above, 
there are other cases, as documented by Dobkin de 
Rios (1968), Rivier & Lindgren (1972), Rodriguez & 
Cavin  (1982) and Albuquerque & Chiappeta (1994), 
where both the healer and the patient (and even other  
people in the ritual) took the plant to hallucinate. In 
addition to other factors, the combination of various 
elements of the ritual (songs and dances, for 
example) can cause a synergism that leads to the 
patient‟s “cure.”  
The role of rituals in healing diseases using 
psychoactive plants 
Some authors have suggested that healing in 
rituals is accomplished through a combination of 
plants with entheogenic properties, songs and prayers 
(Monod, 1976; Bourbonnais-Spear et al., 2007). This 
idea is supported by Albuquerque and Andrade‟s 
(2005) study of African-Brazilian cults. They argued 
that for the remedies to be complete, their 
administration must be accompanied by an 
enchantment to facilitate the healing process. Thus, 
one must consider the complete set of ritual elements 
that create a contagious atmosphere among 
participants, leading to emotional states that can 
produce states of trance (Camargo, 1998).  
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One of the most striking elements in rituals is 
music, whether whistling or magical songs that 
accompany the entire ritual.  Katz & Dobkin de Rios 
(1971) made a great contribution in this area with 
their analysis of the role of whistling in ayahuasca 
healing rituals of Peruvian Amazon natives. They 
concluded that the ingestion of hallucinogenic plants 
and the whistles produced by healers during the 
period of intoxication was the method for invoking 
the forces of nature and the guardian spirits. Later, 
Dobkin de Rios & Katz (1975)  elaborated on their 
findings and established a link between musicality, 
religious rites and healing. They questioned the 
importance of music in ceremonies with 
hallucinogenic plants in Western societies, finding 
that different types of music can evoke particular 
moods and may regulate the hallucinogenic effect of 
the drug administered. Monod (1976), studying the 
Piaroa Indians in South America, believed that the 
songs sung during the rituals had curative and 
preventive effects. Other authors corroborate the 
assertion that music is essential to ritual divination of 
diagnoses and healing. Mentally, the rhythmic 
singing with the drumbeat seems to support the flow 
of visions and minimize fear (see Albuquerque & 
Chiappeta, 1994). Metzner (1998) reports that 
Western psychotherapy and the healing systems of 
shamanic indigenous peoples use plants or 
psychoactive drugs to cure or obtain knowledge, and 





According to the discussions raised by this 
work, we can conclude the following points:  
 
1. There is a strong association between the 
use of hallucinogenic and medicinal substances. This 
association is related to the properties of these 
substances, which may be hallucinogenic or medical 
depending on the dosage. However, no systematic 
study linking ethnographic data with pharmacological 
uses has been found. For example, have 
hallucinogenic substances been used 
pharmacologically in healing ritual activity for all 
diseases?  
2. When substances have different properties 
depending on dosage, researchers tend to assume that 
the medicinal effects were discovered before the 
hallucinogenic effects. This idea has been suggested 
by different studies, but to the best of our knowledge 
it has not been studied and tested. Thus, there is a 
tendency among researchers to consider the 
hallucinogenic effects to be secondary to the medical 
effects.    
3. The different disease treatments using 
hallucinogens can be grouped into three types. In the 
indirect treatment, only the healer takes the 
hallucinogen and receives contact with deities and 
insights about the causes of diseases to diagnose 
and/or obtain treatment for the patient. In the second 
type, direct treatment, the patient takes the 
hallucinogen, which may have active ingredients with 
the desired properties to have a direct effect in curing 
the disease. In the third type, the patient takes the 
hallucinogen, but it does not have active compounds 
for the treatment of the disease in question. Thus, 
healing can be considered a case of "cultural 
placebo.”  
4. In addition to hallucinogens, the other 
elements present in rituals also serve an important 
function in the healing process. Hallucinogenic 
substances may have the ability to influence the kinds 
of visions experienced. In this sense, all these 
elements can have a decisive role in the treatment of 
"cultural diseases." 
 
In conclusion, we believe that further studies 
are needed from the perspectives of ethnobotany, 
ethnopharmacology, phytochemistry and 
anthropology to evaluate the role of these plants in 
the healing systems of different human groups. 
Furthermore, studies in bioprospecting can benefit 
from understanding these systems, which may 
provide new and interesting candidates for the 
development of new medicines.  
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